1. Home
  2. KRRO vs JRS Comparison

KRRO vs JRS Comparison

Compare KRRO & JRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRRO
  • JRS
  • Stock Information
  • Founded
  • KRRO 2014
  • JRS 2001
  • Country
  • KRRO United States
  • JRS United States
  • Employees
  • KRRO N/A
  • JRS N/A
  • Industry
  • KRRO Biotechnology: Pharmaceutical Preparations
  • JRS Finance/Investors Services
  • Sector
  • KRRO Health Care
  • JRS Finance
  • Exchange
  • KRRO Nasdaq
  • JRS Nasdaq
  • Market Cap
  • KRRO 209.6M
  • JRS 231.7M
  • IPO Year
  • KRRO 2019
  • JRS N/A
  • Fundamental
  • Price
  • KRRO $11.42
  • JRS $7.97
  • Analyst Decision
  • KRRO Strong Buy
  • JRS
  • Analyst Count
  • KRRO 7
  • JRS 0
  • Target Price
  • KRRO $85.67
  • JRS N/A
  • AVG Volume (30 Days)
  • KRRO 89.6K
  • JRS 86.6K
  • Earning Date
  • KRRO 05-07-2025
  • JRS 01-01-0001
  • Dividend Yield
  • KRRO N/A
  • JRS 8.87%
  • EPS Growth
  • KRRO N/A
  • JRS N/A
  • EPS
  • KRRO N/A
  • JRS N/A
  • Revenue
  • KRRO $4,821,000.00
  • JRS N/A
  • Revenue This Year
  • KRRO $20.96
  • JRS N/A
  • Revenue Next Year
  • KRRO N/A
  • JRS N/A
  • P/E Ratio
  • KRRO N/A
  • JRS N/A
  • Revenue Growth
  • KRRO N/A
  • JRS N/A
  • 52 Week Low
  • KRRO $11.00
  • JRS $5.95
  • 52 Week High
  • KRRO $98.00
  • JRS $8.00
  • Technical
  • Relative Strength Index (RSI)
  • KRRO 34.02
  • JRS 54.73
  • Support Level
  • KRRO $14.54
  • JRS $7.69
  • Resistance Level
  • KRRO $16.68
  • JRS $7.87
  • Average True Range (ATR)
  • KRRO 1.49
  • JRS 0.15
  • MACD
  • KRRO -0.33
  • JRS -0.00
  • Stochastic Oscillator
  • KRRO 6.24
  • JRS 72.22

About KRRO Korro Bio Inc.

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.

About JRS Nuveen Real Estate Income Fund of Beneficial Interest

Nuveen Real Estate Income Fund is a diversified closed-end investment company. The Fund invests primarily in income-producing common stocks, preferred stocks, convertible preferred stocks, and debt securities issued by real estate companies.

Share on Social Networks: